Natural History, Tumor Growth Kinetics, and Renal Functional Outcomes of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma: A 25-yr Prospective Cohort Study [0.03%]
散发性双侧多灶性乳头状肾细胞癌的自然史、肿瘤生长动力学和肾脏功能结局：一项前瞻性队列研究（随访25年）
Hangcheng Fu,Ruben Blachman-Braun,Lauren Loebach et al.
Hangcheng Fu et al.
Background and objective: Bilateral or multifocal (BMF) papillary renal cell carcinoma (pRCC) arising without a confirmed pathogenic germline variant represents a clinically distinct entity with a poorly defined natural h...
Saline-assisted Fascial Exposure Microultrasound-guided Nerve Preservation During Robotic Prostatectomy: Interim Analysis of a Randomized Controlled Trial [0.03%]
机器人辅助前列腺癌根治术盐水冲刷筋膜暴露组与超声刀组的神经保护效果：一项随机对照试验的中期分析
Adriana M Pedraza,Monali Fatterpekar,Himanshu Joshi et al.
Adriana M Pedraza et al.
Background: Erectile dysfunction remains a major morbidity after radical prostatectomy. The SAFE technique uses real-time, micro-ultrasound-guided low-pressure hydrodissection to enable atraumatic nerve sparing. ...
Prognostic Factors After Radical Cystectomy for Non-muscle-invasive Bladder Cancer: From Prognostication to Patient Selection [0.03%]
根治性膀胱切除术后非肌层浸润性膀胱癌的预后因素：从预后判断到患者选择
Simone Sforza,Felix Lübbersmeyer,Andrea Mari
Simone Sforza
Detection and Localization of Unfavorable-histology Prostate Cancer Using MRI and Whole-mount Histopathology [0.03%]
基于MRI和整块组织病理学的不利病史前列腺癌的检测与定位
Mariluz Rojo Domingo,Anna Dornisch,Christopher C Conlin et al.
Mariluz Rojo Domingo et al.
Background and objective: Detecting localized prostate cancer (PC) with metastatic potential-defined as unfavorable-histology PC (uhPC), comprising Grade Group (GG) ≥3 disease or GG 2 disease with cribriform/intraductal ...
Reducing MRI Use in Organized Prostate Cancer Testing Using Blood-based Biomarkers: The OPT Stockholm3 Study [0.03%]
基于血液的生物标志物在组织化前列腺癌检测中减少MRI使用：OPT Stockholm3研究
Ugo Giovanni Falagario,Shuang Hao,Olof Akre et al.
Ugo Giovanni Falagario et al.
Background and objective: We assessed the feasibility of implementation, reduction in magnetic resonance imaging (MRI) use, and cost implications of integrating Stockholm3 as a reflex blood test in organized prostate canc...
NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol [0.03%]
新BLAST：肌层浸润性膀胱癌新辅助治疗后临床完全缓解的患者进行积极监测与根治性膀胱治疗的对照试点研究- 研究方案
Marie-Pier St-Laurent,Bernhard J Eigl,Scott Tyldesley et al.
Marie-Pier St-Laurent et al.
Although many patients with muscle-invasive bladder cancer (MIBC) achieve a pathologic complete response (CR) following neoadjuvant therapy (NAT), subsequent definitive bladder treatment (DBT) - radical cystectomy (RC) or trimodal therapy (...
PSMA PET in Prostate Cancer: Clinical Value, Access Challenges, and Priorities for Implementation [0.03%]
前列腺癌中的PSMA PET：临床价值、使用障碍及实施重点
Arthur Peyrottes,Léa Turpin,Laura Fernández Hernández et al.
Arthur Peyrottes et al.
Prostate-specific membrane antigen positron emission tomography (PSMA PET) has become an integral component of contemporary prostate cancer (PCa) management, improving disease characterization in clinically relevant settings such as initial...
Validation of an AI-based Histologic Prognostic Biomarker in Patients with Non-muscle-invasive Bladder Cancer Using the Prospective Swedish National Register of Urinary Bladder Cancer [0.03%]
基于人工智能的非肌层浸润性膀胱癌组织学预后生物标志物的验证：前瞻性瑞典膀胱癌国家注册处数据研究
Per-Uno Malmström,Anca Dragomir,Truls Gårdmark
Per-Uno Malmström
Risk-adapted Omission of Systematic Cores in PI-RADS 3 Lesions Based on Prostate-specific Antigen Density, Biopsy Route, and Targeted Core Number: A Multicentre Cohort Study [0.03%]
基于前列腺特异性抗原密度、活检途径和靶向核心数量的PI-RADS 3病变的风险适应系统核心遗漏：一项多中心队列研究
Bogdan Adrian Buhas,Georges Mjaess,Romain Diamand et al.
Bogdan Adrian Buhas et al.
Background: Prostate Imaging Reporting and Data System (PI-RADS) category 3 lesions represent an intermediate-risk group for which the additional diagnostic value of systematic biopsy (SBx) after multiparametric magnetic ...
Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens's Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.04.008 [0.03%]
关于Kelly M. de Ligt，Sarah P. Psutka和Laura S. Mertens致编辑信的回复：当患者拒绝根治性膀胱切除术时：在ICI/ADC围手术期整合三联疗法。《欧洲泌尿肿瘤学》在线发表。DOI:10.1016/j.euo.2026.04.008
Martino Pedrani,Alberto De Giorgi,Andrea Gallina et al.
Martino Pedrani et al.